Business Context and Reporting Period
This Form 8-K filing by Insperity, Inc. (NSP) covers events occurring on May 20, 2021, through May 26, 2021. The report details the expiration of a poison pill rights agreement, the subsequent elimination of the associated preferred stock series, and the results of the 2021 Annual Meeting of Stockholders held on May 24, 2021.
Key Financial Metrics
This filing is a current report regarding corporate governance and capital structure changes. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
- Expiration of Rights Agreement: The Rights Agreement dated May 21, 2020, expired on May 20, 2021, terminating stock purchase rights for Series A Junior Participating Preferred Stock.
- Capital Structure Amendment: On May 25, 2021, the Company filed a certificate of elimination with the Delaware Secretary of State to remove all matters regarding the Series A Preferred Stock from its certificate of incorporation. No shares of this series were outstanding.
Corporate Actions and Governance
The Company held its 2021 Annual Meeting on May 24, 2021. Key outcomes included:
- Director Elections: Class II directors Carol R. Kaufman, John L. Lumelleau, and Paul J. Sarvadi were elected for terms expiring in 2024. All received majority support, though significant "Against" votes were recorded (ranging from approximately 1.5 million to 2.7 million shares).
- Executive Compensation: The advisory vote to approve executive compensation passed with approximately 26.7 million votes "For" and 4.8 million "Against."
- Auditor Ratification: The appointment of Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2021, was ratified with approximately 34.2 million votes "For."
Investor Verification Checklist
- Verify the effective date of the Rights Agreement expiration (May 20, 2021) and confirm no new rights plan has been adopted.
- Review the "Against" vote percentages for the director elections and executive compensation to assess shareholder sentiment.
- Confirm the filing of the Certificate of Elimination with the State of Delaware to ensure the Series A Preferred Stock is legally removed from the capital structure.
- Check subsequent filings for any new material agreements or changes in corporate governance following the Annual Meeting.